back on october 23rd, don in new york quizzed me with a question about abaxis. ied a hood to do some more study. they sell point of care blood analyzers which provide clinicians with rapid blood tests for humans and animals. this gives doctors and vets the opportunity to run profitable, realtime lab tests in their office instead of sending it out to an outside laboratory, like we are so used to. a great idea, but the latest quarter was less than great. the company missed on both earnings and inventory. i would stay away from abxis. and jill turned about pitney bowes. we used to talk about that company in the past. i wanted to do some additional digging to see why the stock's been running. pitney bowes has transformed into a digital communications company, some legacy snail mail products. pbi's partnership with ebay looks promising and the most recent results strengthens the case that the company's new program to stabilize revenues is, indeed, working. i think if we get more signs are sustainable, pbi can move higher into the end of the year. but be careful, the